Proposed Collection; Comment Request; The Jackson Heart Study (JHS), 62476-62477 [E6-17898]
Download as PDF
62476
Federal Register / Vol. 71, No. 206 / Wednesday, October 25, 2006 / Notices
Number of
respondents
Reporting requirements
Reporting requirements 124.704(b) and 707 ............
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to:
John Kraemer, Human Resources and
Housing Branch, Office of Management
and Budget, New Executive Office
Building, Room 10235, Washington, DC
20503.
Dated: October 17, 2006.
Cheryl R. Dammons,
Director, Division of Policy Review and
Coordination.
[FR Doc. E6–17812 Filed 10–24–06; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment
Request; The Jackson Heart Study
(JHS)
SUMMARY: In compliance with the
requirement of section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Heart, Lung, and Blood
Institute (NHLBI), the National
Institutes of Health (NIH) will publish
periodic summaries of proposed
projects to be submitted to the Office of
Responses per
respondent
10
Hours per
response
Total responses
1
10
Management and Budget (OMB) for
review and approval.
Proposed Collection
Title: The Jackson Heart Study:
Annual Follow-up with Third Party
Respondents.
Type of Information Collection
Request: Revision of a currently
approved collection (OMB NO. 0925–
0491).
Need and Use of Information
Collection: This project involves annual
follow-up by telephone of participants
in the JHS study, review of their
medical records, and interviews with
doctors and family to identify disease
occurrence. Interviewers will contact
doctors and hospitals to ascertain
participants’ cardiovascular events.
Information gathered will be used to
further describe the risk factors,
occurrence rates, and consequences of
cardiovascular disease in African
American men and women. Recruitment
of 5,500 JHS participants began in
September 2000 and was completed in
March 2004. 5,302 participants
completed a baseline Exam 1 that
included demographics, psychosocial
inventories, medical history,
anthropometry, resting and ambulatory
blood pressure, phlebotomy and 24hour urine collection, ECG,
echocardiography, and pulmonary
function. JHS Exam 2 began September
26 2005, with a more comprehensive
Total burden
hours
1.25
12.5
Exam 3 beginning in February 2009. The
two new exams include some repeated
measures from Exam 1 and several new
components, including distribution of
self-monitoring blood pressure devices.
The continuation of the study allows
continued assessment of subclinical
coronary disease, left ventricular
dysfunction, progression of carotid
atherosclerosis and left ventricular
hypertrophy, and responses to stress,
racism, and discrimination as well as
new components such as renal disease,
body fat distribution and body
composition, and metabolic
consequences of obesity.
Frequency of Response: One-time.
Affected Public: Individuals or
households; Businesses or other for
profit; not-for-profit institutions.
Type of Respondents: Middle aged
and elderly adults; doctors and staff of
hospitals and nursing homes. The
annual reporting burden is as follows:
Estimated Number of Respondents:
600;
Estimated Number of Responses per
Respondent: 1.0;
Average Burden Hours per Response:
0.5; and
Estimated Total Annual Burden
Hours Requested: 300.
The annualized cost to respondents is
estimated at $6,500. There are no
Capital Costs to report. There are no
Operating or Maintenance Costs to
report.
ESTIMATE OF ANNUAL HOUR BURDEN
Number of
respondents
Type of response
Frequency of
response
Average
time per
response
Annual hour
burden
200
200
1
1
0.17
0.25
34
50
Total ..........................................................................................................
mstockstill on PROD1PC61 with NOTICES
Morbidity & Mortality AFU 3rd Party/Next-of-kin decedents ............................
Morbidity & Mortality AFU 3rd Party Physicians .............................................
400
........................
........................
84
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility;
(2) The accuracy of the agency’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
VerDate Aug<31>2005
15:12 Oct 24, 2006
Jkt 211001
assumptions used; (3) Ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
Ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
the data collection plans and
instruments, contact Ms. Cheryl Nelson,
Project Officer, NIH, NHLBI, 6701
Rockledge Drive, MSC 7934, Bethesda,
MD 20892–7934, or call non-toll-free
number 301–435–0451 or E-mail your
request, including your address to:
NelsonC@nhlbi.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60-days of the date of
this publication.
E:\FR\FM\25OCN1.SGM
25OCN1
Federal Register / Vol. 71, No. 206 / Wednesday, October 25, 2006 / Notices
Dated: October 18, 2006.
Suzanne Freeman,
NHLBI Project Clearance Liaison, National
Institutes of Health.
Dated: September 26, 2006.
Peter Savage,
Acting Director, DPPS, National Institutes of
Health.
[FR Doc. E6–17898 Filed 10–24–06; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
mstockstill on PROD1PC61 with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Director’s Council of Public
Representatives.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Director’s Council of
Public Representatives.
Date: November 3, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: Among the topics proposed for
discussion are: (1) NIH Director’s update: (2)
Discussion on the Role of the Public in the
Research Process; (3) Genome-Wide
Association Studies Briefing; (4) NIH
Foundation Activities Report; (5) Update on
Biomarkers of Disease; (6) NIH
Communications Update; and (6) discussion
and public comment.
Place: National Institutes of Health,
Building 31, Conference Room 6, 9000
Rockville Pike, Bethesda, MD 20892.
Contact Person: Jennifer E. Gorman, NIH
Public Liaison/COPR Coordinator, Office of
Communications and Public Liaison, Office
of the Director, National Institutes of Health,
9000 Rockville Pike, Building 31, Room
5B64, Bethesda, MD 20892, (301) 435–4448,
gormanj@od.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel and airport shuffles
will be inspected before being allowed on
VerDate Aug<31>2005
15:12 Oct 24, 2006
Jkt 211001
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state he purpose of their
visit. Information is also available on the
Institute’s/Center’s home page https://
www.copr.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: October 17, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8882 Filed 10–24–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given on the meeting of the
President’s Cancel Panel.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(9)(B), Title 5 U.S.C., as
amended, because the premature
disclosure of information and the
discussions would likely to significantly
frustrate implementation of
recommendations.
Name of Committee: President’s Cancer
Panel.
Date: December 5, 2006.
Open: December 5, 2006, 8 a.m.–4 p.m.
Agenda: Promoting Healthy Lifestyles to
Reduce the Risk of Cancer.
Place: Oregon Health & Science University
Cancer Institute, 3181 Southwest Sam
Jackson Park Road, Portland, OR 97239.
Closed: December 5, 2006, 4 p.m.–8 p.m.
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
62477
Agenda: The Panel will discuss the
Promoting Healthy Lifestyles to Reduce the
Risk of Cancer and discuss potential topics
for the 2007/2008 series.
Place: Oregon Health & Science University
Cancer Institute, 3181 Southwest Sam
Jackson Park Road, Portland, OR 97239.
Contact Person: Abby Sandler, PhD,
Executive Secretary, National Center
Institute, National Institutes of Health,
Building 6116, Room 212, 6116 Executive
Boulevard, Bethesda, MD 20892, 301/451–
9399.
Any interested person may file written
comments with the committee by forwarding
the comments to the Contact Person listed on
this notice. The comments should include
the name, address, telephone number and,
when applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/pcp/pcp.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: October 17, 2006.
Linda Payne,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8883 Filed 10–24–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel,
E:\FR\FM\25OCN1.SGM
25OCN1
Agencies
[Federal Register Volume 71, Number 206 (Wednesday, October 25, 2006)]
[Notices]
[Pages 62476-62477]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-17898]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment Request; The Jackson Heart Study
(JHS)
SUMMARY: In compliance with the requirement of section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for opportunity for public comment
on proposed data collection projects, the National Heart, Lung, and
Blood Institute (NHLBI), the National Institutes of Health (NIH) will
publish periodic summaries of proposed projects to be submitted to the
Office of Management and Budget (OMB) for review and approval.
Proposed Collection
Title: The Jackson Heart Study: Annual Follow-up with Third Party
Respondents.
Type of Information Collection Request: Revision of a currently
approved collection (OMB NO. 0925-0491).
Need and Use of Information Collection: This project involves
annual follow-up by telephone of participants in the JHS study, review
of their medical records, and interviews with doctors and family to
identify disease occurrence. Interviewers will contact doctors and
hospitals to ascertain participants' cardiovascular events. Information
gathered will be used to further describe the risk factors, occurrence
rates, and consequences of cardiovascular disease in African American
men and women. Recruitment of 5,500 JHS participants began in September
2000 and was completed in March 2004. 5,302 participants completed a
baseline Exam 1 that included demographics, psychosocial inventories,
medical history, anthropometry, resting and ambulatory blood pressure,
phlebotomy and 24-hour urine collection, ECG, echocardiography, and
pulmonary function. JHS Exam 2 began September 26 2005, with a more
comprehensive Exam 3 beginning in February 2009. The two new exams
include some repeated measures from Exam 1 and several new components,
including distribution of self-monitoring blood pressure devices. The
continuation of the study allows continued assessment of subclinical
coronary disease, left ventricular dysfunction, progression of carotid
atherosclerosis and left ventricular hypertrophy, and responses to
stress, racism, and discrimination as well as new components such as
renal disease, body fat distribution and body composition, and
metabolic consequences of obesity.
Frequency of Response: One-time.
Affected Public: Individuals or households; Businesses or other for
profit; not-for-profit institutions.
Type of Respondents: Middle aged and elderly adults; doctors and
staff of hospitals and nursing homes. The annual reporting burden is as
follows:
Estimated Number of Respondents: 600;
Estimated Number of Responses per Respondent: 1.0;
Average Burden Hours per Response: 0.5; and
Estimated Total Annual Burden Hours Requested: 300.
The annualized cost to respondents is estimated at $6,500. There
are no Capital Costs to report. There are no Operating or Maintenance
Costs to report.
Estimate of Annual Hour Burden
----------------------------------------------------------------------------------------------------------------
Number of Frequency of Average time Annual hour
Type of response respondents response per response burden
----------------------------------------------------------------------------------------------------------------
Morbidity & Mortality AFU 3rd Party/Next-of-kin 200 1 0.17 34
decedents......................................
Morbidity & Mortality AFU 3rd Party Physicians.. 200 1 0.25 50
�������������������������������������������������
Total....................................... 400 .............. .............. 84
----------------------------------------------------------------------------------------------------------------
Request for Comments: Written comments and/or suggestions from the
public and affected agencies are invited on one or more of the
following points: (1) Whether the proposed collection of information is
necessary for the proper performance of the function of the agency,
including whether the information will have practical utility; (2) The
accuracy of the agency's estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (3) Ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) Ways to minimize
the burden of the collection of information on those who are to
respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact Ms. Cheryl Nelson, Project Officer, NIH, NHLBI,
6701 Rockledge Drive, MSC 7934, Bethesda, MD 20892-7934, or call non-
toll-free number 301-435-0451 or E-mail your request, including your
address to: NelsonC@nhlbi.nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60-days
of the date of this publication.
[[Page 62477]]
Dated: October 18, 2006.
Suzanne Freeman,
NHLBI Project Clearance Liaison, National Institutes of Health.
Dated: September 26, 2006.
Peter Savage,
Acting Director, DPPS, National Institutes of Health.
[FR Doc. E6-17898 Filed 10-24-06; 8:45 am]
BILLING CODE 4140-01-P